Top news of the week: 10.03.2020.
#BioTech #IWD2020 #InternationalWomensDay #digitalisation #COVID19 #SARS #hcmktg #pharma #communications #MedAffairs
Healthcare
U.S.-Based Biotech Growing into a Giant with AI #BioTech via https://t.co/2sI0UxJbpn https://t.co/hoJjizhBGh
OpenU.S.-Based Biotech 'Growing into a Giant with AI' Research Report
How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report.
RT @lisamjarvis: How has CRISPR changed Jennifer Doudna's life? I spent a day w/the gene-editing pioneer (& this week's @cenmag guest editor!) to see how she's evolved as a leader, mentor, and entrepreneur. #InternationalWomensDay #IWD2020 https://t.co/fKSTsNjXnV
OpenA day with Jennifer Doudna: Trying to keep up with one of the world’s most sought-after scientists
The gene-editing tool CRISPR-Cas9 rerouted Doudna’s career path. What hasn’t changed for the renowned scientist and serial entrepreneur? Living and breathing the science
RT @GideonGil: “They basically import the entire disease-fighting army of antibodies from patients whose bodies have already won”: @matthewherper @adamfeuerstein explain how blood plasma therapy could work against #COVID19 #coronavirus https://t.co/DZxIUN5W4q via @statnews
OpenHow blood plasma from recovered patients could help treat the new coronavirus
The approach is based on the idea that antibodies developed by recovered patients might strengthen the immune system of new patients.
Which Groups Are Most at Risk from the Coronavirus? https://t.co/VObdHSNhvi https://t.co/iALjCXjZ8c
OpenWhich Groups Are Most at Risk from the Coronavirus?
Being elderly, having an underlying illness and possibly being male all increase the risk of dying from an infection with the virus
The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time #BioTech via https://t.co/2sI0UxJbpn https://t.co/Ho4u8TKiPu
Open'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time
The vaccine still needs at least 12 to 18 months of testing in people to determine if it's safe and works to prevent the coronavirus.
RT @businessinsider: The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time https://t.co/rH1taH4LjG
OpenThe inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time
We got the full story of how Moderna went from the genetic code of the virus to shipping a vaccine in 42 days.
Ipsen’s Paul Murasko on how digital can enhance the customer journey https://t.co/3Y3DRTBEAW #pharma #hcmktg
OpenEngaging with customers in a digital world
As part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains the many ways digital can enhance the customer journey – so long as the ...
RT @nextlevel_LS: Paul Tunnah, @pharmaphorum, on the impact of #digitalisation on medical #communications @ our #MedAffairs Leaders Forum Spring 2020 in London: https://t.co/iHUcK4O09O https://t.co/BXlo7ZaxOD
OpenLeaders Forum
The MedAffairs Leaders Forum is Europe's largest gathering of Medical Affairs, Medical Communications & MSL professionals. NextLevel Life Sciences delivers expert speakers to examine these ...